eli lilly clinical trials retatrutide Breaking: New trial data just released. TRIUMPH-1 study results on the triple agonist. Lilly's trial on Retatrutide (triple agonist compound). 80 weeks. Phase 3 data. The results: At 12mg Retatrutide Helped Adults With Obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19














:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)










